Our bodies create antibodies to recognize, neutralize and clear specific pathogens. That's why scientists are looking at neutralizing anbodies as models for therapies against the new coronavirus, SARS-CoV-2.
Several new findings on how the virus’ cell entry tools operate could expedite the design of vaccines, antibodies, antivirals and other therapeutics.
A monoclonal antibody prevents the virus from fusing with cell membranes to gain entry
Visualizing how some patients overcame SARS or MERS could suggest possibilities to combat deadly coronaviruses.